Phase II study of ipilimumab and nivolumab in leptomeningeal carcinomatosis

Phase II study of ipilimumab and nivolumab in leptomeningeal carcinomatosis

Leptomeningeal metastases from solid tumors are a rare complication with a very poor prognosis. Here the authors report the efficacy and safety of combined ipilimumab and nivolumab in patients with leptomeningeal carcinomatosis.

গ্রন্থ-পঞ্জীর বিবরন
প্রধান লেখক: Priscilla K. Brastianos, Matthew R. Strickland, Eudocia Quant Lee, Nancy Wang, Justine V. Cohen, Ugonma Chukwueke, Deborah Anne Forst, April Eichler, Beth Overmoyer, Nancy U. Lin, Wendy Y. Chen, Aditya Bardia, Dejan Juric, Ibiayi Dagogo-Jack, Michael D. White, Jorg Dietrich, Naema Nayyar, Albert E. Kim, Christopher Alvarez-Breckenridge, Maura Mahar, Joana L. Mora, Brian V. Nahed, Pamela S. Jones, Helen A. Shih, Elizabeth R. Gerstner, Anita Giobbie-Hurder, Scott L. Carter, Kevin Oh, Daniel P. Cahill, Ryan J. Sullivan
বিন্যাস: প্রবন্ধ
ভাষা:English
প্রকাশিত: Nature Portfolio 2021-10-01
মালা:Nature Communications
অনলাইন ব্যবহার করুন:https://doi.org/10.1038/s41467-021-25859-y

আন্তর্জাল

https://doi.org/10.1038/s41467-021-25859-y

অনুরূপ উপাদানগুলি